Summary
Five different recombinant vaccinia viruses expressing the envelope antigen of hepatitis B virus (HBsAg) under the control of the P7·5 promoter were constructed. Cell cultures infected with some of the recombinant viruses synthesized both middle (M) and major surface (S) protein of HBsAg. It was shown that the length of the nontranslated sequence preceding preS2-ATG influenced the extracellular or intracellular HBV antigen distribution and the preS2:S antigen ratio. Some recombinants synthesized an M protein that was enlarged by additional 35 amino acids of preS1 domain and was entirely retained within the infected cells. Antibody responses to the S and preS2 antigens in mice revealed significant differences in the immunogenicity of individual recombinants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Altstein AD, Andzhaparidze OG, Antonova TP, Baev AA, Bajsar D, Bendukidze KA, Gorodetsky SI, Zakharova LG, Kryazhevskaya MV, Pashvykina GV, Fodor II, Chernos VI (1986) Double recombinants of vaccinia virus expressing hepatitis B virus surface antigen and herpes virus thymidine kinase. Doklady Akad Nauk SSSR 289: 1493–1496 (in Russian)
Budkowska A, Riottot MM, Dubreil P, Lazizi Y, Brechot CH, Sobczak E, Petit MA, Pillot J (1986) Monoclonal antibody recognizing preS2 epitope and anti-preS2 antibody. J Med Virol 20: 111–125
Burrell CJ, Mac Kay P, Greenaway PJ, Hofschneider PM, Murray K (1979) Expression inEscherichia coli of hepatitis B virus DNA cloned in plasmid pBR322. Nature 279: 43–47.
Cheng KC, Smith GL, Moss B (1986) Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol 60: 337–344
Cheng KC, Moss B (1987) Selective syntheses and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S a S epitopes. J Virol 61: 1286–1290
Hamšíková E, Závadová H, Kutinová L, Ludvíková V, Krchňák V, Němečková Š, Vonka V (1990) Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Arch Virol 113: 283–289
Heermann K-H, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH (1984) Large surface protein of hepatitis B virus containing the pre-S sequence. J Virol 52: 396–402
Heermann K-H, Kruse F, Seifer M, Gerlich WH (1987) Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28: 14–25
Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A (1986) A synthetic peptide vaccine involving the product of the preS(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83: 9174–9178
Kozak M (1986) Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci USA 83: 2850–2854
Kuroki K, Russnak R, Ganem D (1989) Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol Cell Biol 9: 4459–4466
Kutinová L, Němečková Š, Hamšíková E, Press M, Závadová H, Hirsch I, Němeček V, Krchňák V, Smrt J, Slonim D, Vonka V (1990) A recombinant vaccinia virus expressing hepatitis B virus middle surface protein: restricted expression of HBV antigens in human cells. Arch Virol 112: 181–193
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Moss B, Flexner C (1987) Vaccinia virus expression vector. Annu Rev Immunol 5: 305–324
Neurath AR, Kent SBH, Parker K, Prince AM, Strick N, Brotman B, Sproul P (1986) Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4: 35–37
Neurath AR, Kent SBH (1988) The pre-S region of hepadnavirus envelope proteins. In: Marmarosch K, Murphy FA, Shatkin AJ (eds) Advances in virus research, vol 34. Academic Press, San Diego, pp 65–142
Neurath AR, Seto B, Strick N (1989) Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7: 234–236
Pasek M, Goto T, Gilbert W, Zink B, Schaller H, Mac Kay P, Leadbetter G, Murray K (1979) Hepatitis B virus genes and their expression inE. coli. Nature 282: 575–579
Persing DH, Varmus HE, Ganem D (1986) Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 234: 1388–1392
Pourcel C, Louise S, Gervais M, Chenciner N, Dubois MF, Tiollais P (1982) Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA. J Virol 42: 100–1ß5
Rutgers T, Cabezon T, Harford N, Vanderbrugge D, Descurieux M, Van Opstal O, Van Vijnedaele F, Hauser P, Voet P, De Wilde M (1988) Expression of different forms of hepatitis B virus envelope proteins in yeast. In: Zuckerman A (ed) Viral hepatitis and liver disease. AR Liss, New York, pp 304–308
Slonim D, Hulenová M (1969) Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays under an agar overlay. Acta Virol 13: 209–215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Němečková, Š., Kutinová, L., Hamšíková, E. et al. Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Archives of Virology 121, 29–41 (1991). https://doi.org/10.1007/BF01316742
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316742